Clinical Trials Browser

Approved for marketing × INDUSTRY × 3-Iodobenzylguanidine × Clear all

NCT02961491 2019-01-30

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Approved for marketing

Paraganglioma, Pheochromocytoma

NCT00730444 2009-11-09

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma

Approved for marketing

Neuroblastoma